Health Disparities from Economic Burden of Diabetes in Middle-income Countries: Evidence from Mexico

被引:34
|
作者
Arredondo, Armando [1 ]
Reyes, Gabriela [1 ]
机构
[1] Natl Inst Publ Hlth, Res Ctr Hlth Syst, Cuernavaca, Morelos, Mexico
来源
PLOS ONE | 2013年 / 8卷 / 07期
关键词
COST; COMPLICATIONS;
D O I
10.1371/journal.pone.0068443
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The rapid growth of diabetes in middle-income countries is generating disparities in global health. In this context we conducted a study to quantify the health disparities from the economic burden of diabetes in Mexico. Evaluative research based on a longitudinal design, using cost methodology by instrumentation. For the estimation of epidemiological changes during the 2010-2012 period, several probabilistic models were developed using the Box-Jenkins technique. The financial requirements were obtained from expected case management costs by disease and the application of an econometric adjustment factor to control the effects of inflation. Comparing the economic impact in 2010 versus 2012 (p<0.05), there was a 33% increase in financial requirements. The total amount for diabetes in 2011 (US dollars) was $7.7 billion. It includes $3.4 billion in direct costs and $4.3 in indirect costs. The total direct costs were $.4 billion to the Ministry of Health (SSA), serving the uninsured population; $1.2 to the institutions serving the insured population (Mexican Institute for Social Security-IMSS-, and Institute for Social Security and Services for State Workers-ISSSTE-); $1.8 to users; and $.1 to Private Health Insurance (PHI). If the risk factors and the different health care models remain as they currently are in the analyzed institutions, health disparities in terms of financial implications will have the greatest impact on users' pockets. In middle-income countries, health disparities generated by the economic burden of diabetes is one of the main reasons for catastrophic health expenditure. Health disparities generated by the economic burden of diabetes suggests the need to design and review the current organization of health systems and the relevance of moving from biomedical models and curative health care to preventive and socio-medical models to meet expected challenges from diseases like diabetes in middle-income countries.
引用
下载
收藏
页数:6
相关论文
共 50 条
  • [21] The emergency burden in low and middle-income countries
    Delaney, Peter G.
    Eisner, Zachary J.
    Geduld, Heike
    SURGERY, 2024, 176 (02) : 528 - 530
  • [22] The burden of diabetes and use of diabetes care in humanitarian crises in low-income and middle-income countries
    Kehlenbrink, Sylvia
    Smith, James
    Ansbro, Eimhin
    Fuhr, Daniela C.
    Cheung, Anson
    Ratnayake, Ruwan
    Baulle, Philippa
    Jobanputra, Kiran
    Perel, Pablo
    Roberts, Bayard
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (08): : 638 - 647
  • [23] Review of the epidemiological evidence for physical activity and health from low-and middle-income countries
    Milton, Karen
    Macniven, Rona
    Bauman, Adrian
    GLOBAL PUBLIC HEALTH, 2014, 9 (04) : 369 - 381
  • [24] Non-Linear Impact of Income Inequality on Mental Health: Evidence from Low and Middle-Income Countries
    Mishra, Ankita
    Hailemariam, Abebe
    Srivastava, Preety
    Maheshwari, Greeni
    STUDIES IN NONLINEAR DYNAMICS AND ECONOMETRICS, 2024,
  • [25] Alcohol burden in low-income and middle-income countries
    Connor, Jason P.
    Hall, Wayne
    LANCET, 2015, 386 (10007): : 1922 - 1924
  • [26] Income differences, trade and institutions: empirical evidence from low and middle-income countries
    Sujianto, Agus Eko
    Suryanto, Tulus
    BUSINESS AND ECONOMIC HORIZONS, 2018, 14 (02) : 217 - 228
  • [27] Is the Relationship Between Financial Development and Economic Growth Monotonic? Evidence from a Sample of Middle-Income Countries
    Samargandi, Nahla
    Fidrmuc, Jan
    Ghosh, Sugata
    WORLD DEVELOPMENT, 2015, 68 : 66 - 81
  • [28] Does economic growth reduce multidimensional poverty? Evidence from low- and middle-income countries
    Balasubramanian, P.
    Burchi, F.
    Malerba, D.
    WORLD DEVELOPMENT, 2023, 161
  • [29] Cancer burden in low-income and middle-income countries
    Sharmila Anandasabapathy
    Chite Asirwa
    Surbhi Grover
    Chemtai Mungo
    Nature Reviews Cancer, 2024, 24 : 167 - 170
  • [30] Cancer burden in low-income and middle-income countries
    Anandasabapathy, Sharmila
    Asirwa, Chite
    Grover, Surbhi
    Mungo, Chemtai
    NATURE REVIEWS CANCER, 2024, 24 (03) : 167 - 170